Article
eNOS gene therapy exacerbates hepatic ischemia-reperfusion injury in diabetes: a role for eNOS uncoupling.
Circulation research - 7 Jul 2006
Elrod John W, Duranski Mark R, Langston Will, Greer James J M, Tao Ling, Dugas Tammy R, Kevil Christopher G, Champion Hunter C, Lefer David J
Abstract excerpt
Previous studies indicate that endothelial nitric oxide synthase (eNOS) function is impaired in diabetes as a result of increased vascular generation of reactive oxygen species. We hypothesized that eNOS gene therapy would augment NO. bioavailability and protect against hepatic ischemia-reperfusion (I-R) injury in type 2 diabetes mellitus. We developed a transgenic (Tg) diabetic mouse in which eNOS is...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
